Pharmaceuticals Drug Database
[
Log in
]
Home
Company
EU
Actelion
Almirall
AstraZeneca
Basilea
Bayer
Cosmo
Crucell
Genmab
GlaxoSmithKline
Intercell
Ipsen
Lundbeck
Merck KGaA
Newron
Novartis
Novo Nordisk
Orion
Recordati
Roche
Sanofi
Shire
UCB
US
Abbott Labs
Amgen
Amylin
Biogen IDEC
Bristol Myers Squibb
Celgene
Cephalon
Elan
Eli Lilly
Forest Laboratories
Gilead
Human Genome Sciences
Johnson & Johnson
Merck
Mylan
Nektar Therapeutics
NPS Pharmaceuticals
Onyx
PDL BioPharma
Pfizer
Regeneron
Teva
Watson
JPN
Astellas
Chugai
Daiichi Sankyo
Eisai
Nippon Kayaku
Nippon Organon
Otsuka
Santen
Takeda
Teijin
Sector
Large Pharma
Abbott Labs
AstraZeneca
Bristol Myers Squibb
Eli Lilly
GlaxoSmithKline
Johnson & Johnson
Merck
Novartis
Pfizer
Roche
Sanofi
Large Biotech
Amgen
Amylin
Biogen IDEC
Celgene
Gilead
Mid-Sized Pharma
Almirall
Bayer
Elan
Forest Laboratories
Ipsen
Lundbeck
Merck KGaA
Mylan
Nektar Therapeutics
Novo Nordisk
Orion
Recordati
Shire
Teva
UCB
Watson
Small Biotech
Actelion
Basilea
Cephalon
Cosmo
Crucell
Genmab
Human Genome Sciences
Intercell
Newron
NPS Pharmaceuticals
Onyx
PDL BioPharma
Regeneron
Japan
Astellas
Chugai
Daiichi Sankyo
Eisai
Otsuka
Santen
Takeda
Teijin
Browse
About
Search:
Novartis
- BAF312 (BAF312)
Company:
Brand:
Generic:
Therapeutic Category:
Region:
Dev Status:
Lic Status:
Project Type:
Molecule Type:
Peak Sales:
$m
Decay:
Launch Date:
Plateau:
Peak Year:
Curve:
Patent Expiry:
Average Margin:
%
Generic Entry:
NPV:
$m
Probability:
%
NPV per share:
SFR
Input Margin:
%
Total NPV:
%
Indication:
Mechanism:
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
153
278
375
444
486
500
500
500
500
0
News Items
Drug Comments
Drug
Company
Patent
Private
Jan 09 - filing 2012+e. .
Save
Type:
CHMP
Data Exclusivity
Filing
Filing (EU)
Filing (US)
Generic Entry
News
other
Patent Expiry
PDUFA
Sold / Returned
Trial Data
Trial Enrollment Complete
Trial Initiation
US Approval
Status:
Occurred
Overdue
Pending
Date:
M:
-
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
Q:
-
Q1
Q2
Q3
Q4
H:
-
H1
H2
Yr:
-
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
Comment:
Source: